8-(1-benzylbenzimidazol-2-yl)-2-methyl-7H-[1]benzofuro[2,3-b]pyridin-7-ide;tetrakis([4-(2-deuteriopropan-2-yl)-6-[4-(trideuteriomethyl)benzene-6-id-1-yl]-3-pyridinyl]-trimethylgermane);8-[1-(2,6-dimethylphenyl)benzimidazol-2-yl]-2-methyl-7H-[1]benzofuro[2,3-b]pyridin-7-ide;tetrakis(iridium);2-methyl-8-[1-(2,4,6-trimethylphenyl)benzimidazol-2-yl]-7H-[1]benzofuro[2,3-b]pyridin-7-ide;10-(1-phenylbenzimidazol-2-yl)-9H-[1]benzofuro[3,2-c]isoquinolin-9-ide
C181H172Ge4Ir4N16O4-8 — CID 158119536
Data last refreshed: (MolForge compound catalog, from PubChem)
About 8-(1-benzylbenzimidazol-2-yl)-2-methyl-7H-[1]benzofuro[2,3-b]pyridin-7-ide;tetrakis([4-(2-deuteriopropan-2-yl)-6-[4-(trideuteriomethyl)benzene-6-id-1-yl]-3-pyridinyl]-trimethylgermane);8-[1-(2,6-dimethylphenyl)benzimidazol-2-yl]-2-methyl-7H-[1]benzofuro[2,3-b]pyridin-7-ide;tetrakis(iridium);2-methyl-8-[1-(2,4,6-trimethylphenyl)benzimidazol-2-yl]-7H-[1]benzofuro[2,3-b]pyridin-7-ide;10-(1-phenylbenzimidazol-2-yl)-9H-[1]benzofuro[3,2-c]isoquinolin-9-ide
8-(1-benzylbenzimidazol-2-yl)-2-methyl-7H-[1]benzofuro[2,3-b]pyridin-7-ide;tetrakis([4-(2-deuteriopropan-2-yl)-6-[4-(trideuteriomethyl)benzene-6-id-1-yl]-3-pyridinyl]-trimethylgermane);8-[1-(2,6-dimethylphenyl)benzimidazol-2-yl]-2-methyl-7H-[1]benzofuro[2,3-b]pyridin-7-ide;tetrakis(iridium);2-methyl-8-[1-(2,4,6-trimethylphenyl)benzimidazol-2-yl]-7H-[1]benzofuro[2,3-b]pyridin-7-ide;10-(1-phenylbenzimidazol-2-yl)-9H-[1]benzofuro[3,2-c]isoquinolin-9-ide (PubChem CID 158119536) has the molecular formula C181H172Ge4Ir4N16O4-8 and a molecular weight of 3710.88 g/mol. Its IUPAC name is 8-(1-benzylbenzimidazol-2-yl)-2-methyl-7H-[1]benzofuro[2,3-b]pyridin-7-ide;tetrakis([4-(2-deuteriopropan-2-yl)-6-[4-(trideuteriomethyl)benzene-6-id-1-yl]-3-pyridinyl]-trimethylgermane);8-[1-(2,6-dimethylphenyl)benzimidazol-2-yl]-2-methyl-7H-[1]benzofuro[2,3-b]pyridin-7-ide;tetrakis(iridium);2-methyl-8-[1-(2,4,6-trimethylphenyl)benzimidazol-2-yl]-7H-[1]benzofuro[2,3-b]pyridin-7-ide;10-(1-phenylbenzimidazol-2-yl)-9H-[1]benzofuro[3,2-c]isoquinolin-9-ide.
Molecular Properties
| Compound Name | 8-(1-benzylbenzimidazol-2-yl)-2-methyl-7H-[1]benzofuro[2,3-b]pyridin-7-ide;tetrakis([4-(2-deuteriopropan-2-yl)-6-[4-(trideuteriomethyl)benzene-6-id-1-yl]-3-pyridinyl]-trimethylgermane);8-[1-(2,6-dimethylphenyl)benzimidazol-2-yl]-2-methyl-7H-[1]benzofuro[2,3-b]pyridin-7-ide;tetrakis(iridium);2-methyl-8-[1-(2,4,6-trimethylphenyl)benzimidazol-2-yl]-7H-[1]benzofuro[2,3-b]pyridin-7-ide;10-(1-phenylbenzimidazol-2-yl)-9H-[1]benzofuro[3,2-c]isoquinolin-9-ide |
|---|---|
| PubChem CID | 158119536 |
| Molecular Formula | C181H172Ge4Ir4N16O4-8 |
| Molecular Weight | 3710.88 g/mol |
| Exact Mass | 3717.02 |
| IUPAC Name | 8-(1-benzylbenzimidazol-2-yl)-2-methyl-7H-[1]benzofuro[2,3-b]pyridin-7-ide;tetrakis([4-(2-deuteriopropan-2-yl)-6-[4-(trideuteriomethyl)benzene-6-id-1-yl]-3-pyridinyl]-trimethylgermane);8-[1-(2,6-dimethylphenyl)benzimidazol-2-yl]-2-methyl-7H-[1]benzofuro[2,3-b]pyridin-7-ide;tetrakis(iridium);2-methyl-8-[1-(2,4,6-trimethylphenyl)benzimidazol-2-yl]-7H-[1]benzofuro[2,3-b]pyridin-7-ide;10-(1-phenylbenzimidazol-2-yl)-9H-[1]benzofuro[3,2-c]isoquinolin-9-ide |
| SMILES | Cc1cc(C)c(-n2c(-c3[c-]ccc4c3oc3nc(C)ccc34)nc3ccccc32)c(C)c1.Cc1ccc2c(n1)oc1c(-c3nc4ccccc4n3-c3c(C)cccc3C)[c-]ccc12.Cc1ccc2c(n1)oc1c(-c3nc4ccccc4n3Cc3ccccc3)[c-]ccc12.[2H]C([2H])([2H])c1c[c-]c(-c2cc(C([2H])(C)C)c([Ge](C)(C)C)cn2)cc1.[2H]C([2H])([2H])c1c[c-]c(-c2cc(C([2H])(C)C)c([Ge](C)(C)C)cn2)cc1.[2H]C([2H])([2H])c1c[c-]c(-c2cc(C([2H])(C)C)c([Ge](C)(C)C)cn2)cc1.[2H]C([2H])([2H])c1c[c-]c(-c2cc(C([2H])(C)C)c([Ge](C)(C)C)cn2)cc1.[Ir].[Ir].[Ir].[Ir].[c-]1ccc2c(oc3c4ccccc4cnc23)c1-c1nc2ccccc2n1-c1ccccc1 |
| InChI | InChI=1S/C28H16N3O.C28H22N3O.C27H20N3O.C26H18N3O.4C18H24GeN.4Ir/c1-2-10-19(11-3-1)31-24-16-7-6-15-23(24)30-28(31)22-14-8-13-21-25-27(32-26(21)22)20-12-5-4-9-18(20)17-29-25;1-16-14-17(2)25(18(3)15-16)31-24-11-6-5-10-23(24)30-27(31)22-9-7-8-20-21-13-12-19(4)29-28(21)32-26(20)22;1-16-8-6-9-17(2)24(16)30-23-13-5-4-12-22(23)29-26(30)21-11-7-10-19-20-15-14-18(3)28-27(20)31-25(19)21;1-17-14-15-20-19-10-7-11-21(24(19)30-26(20)27-17)25-28-22-12-5-6-13-23(22)29(25)16-18-8-3-2-4-9-18;4*1-13(2)16-11-18(15-9-7-14(3)8-10-15)20-12-17(16)19(4,5)6;;;;/h1-13,15-17H;5-8,10-15H,1-4H3;4-10,12-15H,1-3H3;2-10,12-15H,16H2,1H3;4*7-9,11-13H,1-6H3;;;;/q8*-1;;;;/i;;;;4*3D3,13D;;;; |
| InChIKey | BSLCXIZJBBMTIE-BDUPUGHFSA-N |
| XLogP | 44.92 |
| TPSA | 226.96 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 20 |
| Rotatable Bonds | 25 |
| Heavy Atoms | 209 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3710.88 |
| LogP ≤ 5 | 44.92 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 20 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158119536 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.